ZIOPHARM Oncology Stock Price

-0.0554 (-5.86%)
Upgrade to Real-Time
Regular Market
Volume 804,552
Bid Price 0.8906
Ask Price 0.8998
News -
Day High 0.9155


52 Week Range


Day Low 0.87
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ZIOPHARM Oncology Inc ZIOP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0554 -5.86% 0.8906 12:43:43
Open Price Low Price High Price Close Price Prev Close
0.89 0.87 0.9155 0.946
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,246 804,552 $ 0.8905021 $ 716,455 - 0.851 - 5.95
Last Trade Time Type Quantity Stock Price Currency
12:43:46 50 $ 0.8997 USD


Draw Mode:

ZIOPHARM Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 192.50M 216.15M 208.06M $ - $ - -0.39 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 459.87k 4.60%

more financials information »

ZIOPHARM Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZIOP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.991.0650.8510.94095711,799,939-0.0994-10.04%
1 Month1.291.340.8511.102,212,419-0.3994-30.96%
3 Months1.5651.680.8511.292,281,475-0.6744-43.09%
6 Months2.2452.490.8511.712,777,796-1.35-60.33%
1 Year3.545.950.8512.642,486,296-2.65-74.84%
3 Years2.487.250.8513.272,026,902-1.59-64.09%
5 Years5.827.880.8513.641,794,575-4.93-84.7%

ZIOPHARM Oncology Description

ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.